SARS-CoV-2 Testing and Changes in Primary Care Services in a Multistate Network of Community Health Centers during the COVID-19 Pandemic

TY - JOUR

T1 - SARS-CoV-2 Testing and Changes in Primary Care Services in a Multistate Network of Community Health Centers during the COVID-19 Pandemic

AU - Heintzman, John

AU - O'malley, Jean

AU - Marino, Miguel

AU - Todd, Jonathan V.

AU - Stange, Kurt C.

AU - Huguet, Natalie

AU - Gold, Rachel

N1 - Funding Information: Funding/Support: This study was supported by the Ministry of Science and Technology of the People’s Republic of China (grant 2020YFC0846300) and by the Beijing Science and Technology Planning Project (Z201100005420010). Role of the Funders/Sponsors: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Disclaimer: The opinions expressed herein reflect the collective views of the coauthors and do not necessarily represent the official position of the authors’ affiliated institutions. 1. Li Q; 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team. An outbreak of NCIP (2019-nCoV) infection in China—Wuhan, Hubei Province, 2019–2020. China CDC Wkly. 2020;2(5):79–80. doi:10.46234/ccdcw2020.022 2. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)—China, 2020. China CDC Wkly. 2020;2(8):113–122. doi:10. 46234/ccdcw2020.032 3. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-1242. doi:10.1001/jama.2020.2648 4. Zhou L, Wu Z, Li Z, et al One hundred days of COVID-19 prevention and control in China. Clin Infect Dis. Published online June 5, 2020. doi:10.1093/cid/ ciaa725 5. Wu Z, McGoogan JM. Asymptomatic and pre-symptomatic COVID-19 in China. Infect Dis Poverty. 2020;9(1):72. doi:10.1186/s40249-020-00679-2 6. Zhou L, Liu JM, Dong XP, McGoogan JM, Wu ZY. COVID-19 seeding time and doubling time model: an early epidemic risk assessment tool. Infect Dis Poverty. 2020;9(1):76. doi:10.1186/s40249-020-00685-4 Funding Information: Funding/Support: This work was supported by the National Cancer Institute of the National Institutes of Health under award No. P50CA244289. This work was also supported by a grant from the Patient Centered Outcomes Research Network (Accelerating Data Value Across a National Community Health Center Network Clinical Research Network phase 3). Role of the Funder/Sponsor: These funders had no role in the specific design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional Contributions: We acknowledge Pedro Rivera, MS; Erika Cottrell, PhD; Teresa Schmidt, PhD; Annie Larson, PhD; Rebecca Block, PhD; Matthew Jones, MS (OCHIN); and Jennifer DeVoe, MD, DPhil (Oregon Health & Science University), for reviewing the manuscript. Dr DeVoe received compensation through the National Cancer Institute award cited above. The other individuals did not receive compensation for their contributions. Additional Information: This program was launched by the National Cancer Institute as part of the Cancer Moonshot. Funding Information: PCORNet during the conduct of the study and, in other similar research projects, receiving funding from the National Institutes of Health (the National Institute of Minority Health and Health Disparities and the National Institute on Aging) and the Agency for Healthcare Research and Quality. Dr O'Malley reported receiving grants from the National Cancer Institute during the conduct of the study. Dr Marino reported receiving grants from the National Cancer Institute during the conduct of the study. Dr Huguet reported receiving grants from the National Cancer Institute during the conduct of the study. Dr Gold reported receiving grants from the National Institutes of Health during the conduct of the study. No other disclosures were reported.

PY - 2020/10/13

Y1 - 2020/10/13

UR - http://www.scopus.com/inward/record.url?scp=85091005681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85091005681&partnerID=8YFLogxK

U2 - 10.1001/jama.2020.15891

DO - 10.1001/jama.2020.15891

M3 - Letter

C2 - 32870237

AN - SCOPUS:85091005681

SN - 0098-7484

VL - 324

SP - 1459

EP - 1462

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 14

ER -